Gemcitabine for Advanced Salivary Cancer: A Phase II Study
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Gemcitabine (Primary)
- Indications Salivary gland cancer
- Focus Therapeutic Use
- 17 Jan 2017 Status changed from active, no longer recruiting to completed.
- 17 Sep 2005 New trial record.